A preview of this full-text is provided by Springer Nature.
Content available from Biological Trace Element Research
This content is subject to copyright. Terms and conditions apply.
Vol.:(0123456789)
Biological Trace Element Research (2025) 203:2149–2158
https://doi.org/10.1007/s12011-024-04338-7
RESEARCH
Health Risk Assessment ofToxic Metal(loids) Consumed Through
Plant‑Based Anti‑diabetic Therapeutics Collected intheNorthern
Divisional City ofRajshahi, Bangladesh
NazmulIslam1· RausanZamir2· OmarFaruque3
Received: 19 May 2024 / Accepted: 5 August 2024 / Published online: 12 August 2024
© The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2024
Abstract
The present study investigates human health risks upon consumption of herbal medicines in terms of ten toxic metalloids in
20 plant-based anti-diabetic therapeutics. The analysis of metalloids was determined by an atomic absorption spectrometer
after microwave-assisted digestion. The computation of hazard quotients (HQ) and hazard indexes (HI) of metalloids leads
to the assessment of non-carcinogenic health risks. Carcinogenic risk was assessed based on cancer slope factor (CSF) and
chronic daily intake (CDI) values. Comparison with WHO regulatory cut-off points for each metalloid: seven samples for
Mn, 12 samples for Hg, three samples for Cu, eight samples for Ni, four samples for Cd, two samples for Pb, one sample
for Cr, and eight samples for Zn are unsafe to consume. Non-carcinogenic human health risk is predicted for Mn in seven
samples, Fe in one sample, Hg in ten samples, Cu in three samples, Ni in one sample, and Pb in two samples. HI values
greater than 1 predict non-carcinogenic health risk in thirteen samples. Incremental lifetime cancer risk (ILCR) remains for
As (inorganic) in 12 samples, Cr (+ 6) in one sample, and Pb in no samples. To guarantee consumer safety, the implementa-
tion of strict monitoring is suggested.
Keywords Plant-based anti-diabetic therapeutics· Carcinogenic and non-carcinogenic risks· Hazard quotient· Hazard
index· Incremental lifetime cancer risk
Introduction
Plant-based therapeutics are herbal drugs that are prepared
from different medicinal herbs. Therapeutics are prone
to contamination with metalloids due to their source and
nature. Herbs can be contaminated with metalloids dur-
ing growing, harvesting, and processing. Metalloids are
considered persistent pollutants due to their non-biodeg-
radability in nature [1, 2]. Different natural and anthropo-
genic activities render them available in nature. Continuous
urbanization and industrialization in the developing world
have led to high levels of metalloid contamination in the soil
and surrounding environment [3, 4]. Entry routes for toxic
metalloids in herbs in different stages are believed to be the
following: polluted soils, industrial emissions, transporta-
tion, water used in irrigation, fertilizers and pesticides, and
storage processes [5–7]. The manufacturing of herbs into
finished formulations also contributes to metalloid contami-
nation [8].
Plant-based therapeutics are conventionally used for
the treatment and prevention of different chronic and acute
diseases like diabetes, hypertension, stomach pain, and
headaches [5, 9]. With an increasing aging population and
a change in lifestyle, chronic diseases like diabetes are on
the rise. For the prevention and management of the dis-
ease, along with allopathic drugs, plant-based anti-diabetic
therapeutics are frequently used health resources [10, 11].
* Nazmul Islam
nazmul.acce.26@gmail.com
Rausan Zamir
rsnzamir@gmail.com
Omar Faruque
faruque.nft.just@gmail.com
1 Department ofTextile Engineering, Daffodil International
University, Dhaka, Bangladesh
2 Department ofChemistry, University ofRajshahi, Rajshahi,
Bangladesh
3 Department ofNutrition andFood Technology, Jashore
University ofScience andTechnology, Jashore, Bangladesh
Content courtesy of Springer Nature, terms of use apply. Rights reserved.